Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Annales De Biologie Clinique
|
January 9, 2026
Clinical biology and artificial intelligence: Objectives of the SFBC Workgroup
Walid Sabeur, Pierre-Adrien Bihl, Bruno Gauthier, et al.
Plos One
|
February 20, 2014
Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder
Sylvain Lehmann, Aroa Relano-Gines, Sarah Resina, et al.
Neuromuscular Disorders : NMD
|
October 31, 2020
The importance of an integrated genotype-phenotype strategy to unravel the molecular bases of titinopathies
Aurélien Perrin, Raul Juntas Morales, François Rivier, et al.
The Lancet. Neurology
|
September 3, 2018
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
Juan Fortea, María Carmona-Iragui, Bessy Benejam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 26, 2013
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis
Sylvain Lehmann, Susanna Schraen, Isabelle Quadrio, et al.
Alzheimer'S Research & Therapy
|
February 2, 2022
The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone
Constance Delaby, Teresa Estellés, Nuole Zhu, et al.
Alzheimer'S Research & Therapy
|
December 6, 2014
A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles
Sylvain Lehmann, Julien Dumurgier, Susanna Schraen, et al.
Current Alzheimer Research
|
January 11, 2018
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers
Olivier Vercruysse, Claire Paquet, Audrey Gabelle, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 9, 2021
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias
Daniel Alcolea, Constance Delaby, Laia Muñoz, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2019
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
Daniel Alcolea, Jordi Clarimón, María Carmona-Iragui, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Annales De Biologie Clinique
|
January 9, 2026
Clinical biology and artificial intelligence: Objectives of the SFBC Workgroup
Walid Sabeur, Pierre-Adrien Bihl, Bruno Gauthier, et al.
Plos One
|
February 20, 2014
Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder
Sylvain Lehmann, Aroa Relano-Gines, Sarah Resina, et al.
Neuromuscular Disorders : NMD
|
October 31, 2020
The importance of an integrated genotype-phenotype strategy to unravel the molecular bases of titinopathies
Aurélien Perrin, Raul Juntas Morales, François Rivier, et al.
The Lancet. Neurology
|
September 3, 2018
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
Juan Fortea, María Carmona-Iragui, Bessy Benejam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 26, 2013
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis
Sylvain Lehmann, Susanna Schraen, Isabelle Quadrio, et al.
Alzheimer'S Research & Therapy
|
February 2, 2022
The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone
Constance Delaby, Teresa Estellés, Nuole Zhu, et al.
Alzheimer'S Research & Therapy
|
December 6, 2014
A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles
Sylvain Lehmann, Julien Dumurgier, Susanna Schraen, et al.
Current Alzheimer Research
|
January 11, 2018
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers
Olivier Vercruysse, Claire Paquet, Audrey Gabelle, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 9, 2021
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias
Daniel Alcolea, Constance Delaby, Laia Muñoz, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 26, 2019
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
Daniel Alcolea, Jordi Clarimón, María Carmona-Iragui, et al.
Page
of 8